|Articles|November 1, 2017
Talking Pharma Reputation with Bioethics International
Author(s)Michelle Maskaly
Jennifer Miller talks about about pharma's reputation problem.
Advertisement
Pharm Exec Editor, Michelle Maskaly sat down with Jennifer Miller, the founder & board president of Bioethics International. In this brief video, Jennifer talks about pharma's reputation.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Bayer Shares Briefly Dip After Activist Investor Offloads Millions of Dollars in Company Stock
2
Pharmaceutical Executive Daily: FDA Issues Warning Letter to ImmunityBio
3
Pharma M&A Roundup: Merck to Acquire Terns Pharmaceuticals, Shionogi to Acquire 50% of Apnimed’s Ownership of Shionogi-Apnimed Sleep Science
4
FDA Sends Warning Letter to ImmunityBio for Misleading Claims in Advertisement
5